DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 116 filers reported holding DICE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.21 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,313,632 | +637.7% | 717,039 | +354.9% | 0.01% | +600.0% |
| Q1 2023 | $4,515,727 | -15.4% | 157,617 | -7.8% | 0.00% | 0.0% |
| Q4 2022 | $5,335,418 | +521.1% | 171,007 | +303.7% | 0.00% | – |
| Q3 2022 | $859,000 | +290.5% | 42,361 | +199.4% | 0.00% | – |
| Q2 2022 | $220,000 | -11.6% | 14,150 | +8.6% | 0.00% | – |
| Q1 2022 | $249,000 | -80.5% | 13,035 | -66.6% | 0.00% | – |
| Q3 2021 | $1,277,000 | – | 39,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $83,343,000 | 29.17% |
| Sands Capital Ventures, LLC | 3,148,970 | $79,700,000 | 11.81% |
| OUP Management Co., LLC | 536,693 | $13,584,000 | 6.12% |
| New Leaf Venture Partners, L.L.C. | 556,693 | $14,090,000 | 5.10% |
| Logos Global Management LP | 1,664,251 | $42,122,000 | 4.34% |
| Asymmetry Capital Management, L.P. | 185,201 | $4,687,000 | 2.49% |
| Deep Track Capital, LP | 1,341,004 | $33,941,000 | 2.40% |
| RA Capital Management | 5,208,911 | $131,838,000 | 2.32% |
| Soleus Capital Management, L.P. | 810,940 | $20,525,000 | 2.06% |
| Miller Investment Management, LP | 180,901 | $4,579,000 | 0.66% |